Outlook Therapeutics (41O.STU) Q2 2026 Earnings

14MayConfirmed
Q1 2026
Next
-0.19
-0.16
-0.13
-0.1

Details

Expected EPS
-0.10378438218
Actual EPS
N/A
Surprise EPS
0.1
Surprise Percent
+100%

Description

Outlook Therapeutics (41O.STU) will report earnings of for Q2 2026 on May 14, 2026.

0 Comments

Share your thoughts